Global Citizenship: The Future of U.S.-China Collaborations
The Knowledge Base: The Era of Advanced Packaging
Standard of Excellence: Finding and Developing Future Leaders in Manufacturing
Enable Injections Partners with Flex for Wearable Injector Production
February 4, 2016 | FlexEstimated reading time: 1 minute
Enable Injections Inc., the developer and manufacturer of wearable medical devices that enable easy patient self-administration of high volume injectable drugs, has entered into a product development and manufacturing partnership with Flex, the global sketch-to-scale solutions company that designs and builds intelligent products for a connected world.
As part of the deal, Enable Injections and Flex will collaborate on the design, development and production of customized wearable injector systems for pharmaceutical company products and clinical trials.
"Effective design of wearable medical devices requires that we innovate on multiple fronts, pushing the boundaries of wearable technology, medical device development, and manufacturing processes," said Paul Humphries, president of High Reliability Solutions at Flex. "With their track record of quality and innovation, Enable Injections is an ideal partner in this process. We are proud to have been selected as Enable Injections’ manufacturing partner, and thrilled to be helping bring innovative, high quality wearable medical devices to the pharmaceutical and biotech industries."
According to Enable Injections, the company's novel injectors – based on pain-free injection technology and preferred by patient panels – provide customers with numerous advantages, including:
- Subcutaneous delivery of up to 50mL doses of high volume and/or viscous biologics
- Ability to monitor compliance and capture data utilizing optional Bluetooth connectivity and a mobile app to provide a connected healthcare solution
- Passive warming of drug product, eliminating the 30-minute wait for refrigerated vials to reach room temperature
- Automated mixing and reconstitution, reducing formulation time and drug development costs
- Use of standard vials, cartridges and syringes, and existing container closures
- Facilitation of in-home therapy, reducing healthcare system costs
"Flex is the recognized leader in high volume manufacturing of body-worn injection systems. We very much look forward to partnering with Flex to satisfy pharmaceutical and biotech company requirements for high reliability, high volume manufacturing," said Michael D. Hooven, Enable Injections' president and CEO.
Share on:
Suggested Items
Flex Completes Acquisition of Crown Technical Systems
12/04/2024 | PR NewswireFlex recently announced that it has completed its previously announced $325 million all-cash acquisition of Crown Technical Systems, a leader in fully integrated power distribution and protection systems.
Flex PCB Design Best Practices with Dave Lackey
12/04/2024 | Brittany Martin, I-Connect007David Lackey, a flex circuit expert at American Standard Circuits, speaks about the advantages and challenges of designing with flexible and rigid-flex PCBs. He also discusses how consulting before the design phase can save time and costs by avoiding manufacturing issues and highlights the reliability and packaging benefits of flex technology, especially for compact designs in sectors like aerospace.
Flexible Electronics Market to Reach $75.04 Billion by 2032
12/03/2024 | Globe NewswireThe SNS Insider report indicates that,“The Flexible Electronics Market Size was valued at USD 32.65 Billion in 2023 and is expected to reach USD 75.04 Billion by 2032 and grow at a CAGR of 9.72% over the forecast period 2024-2032.”
ULVAC Launches New Deposition System for Semiconductor Applications
12/02/2024 | JCN NewswireULVAC, Inc. has started accepting orders for the ENTRON-EXX, a new multi-chamber deposition system for semiconductor applications. The ENTRON-EXX builds on the proven productivity and flexibility of its predecessor, the ENTRON-EX W300, while offering enhanced data intelligence and expandability.
Flex Announces Kevin Krumm as Chief Financial Officer
11/27/2024 | FlexFlex announced that Kevin S. Krumm will join the company as Chief Financial Officer (CFO), effective January 6, 2025. He will succeed Jaime Martinez, interim CFO, who will remain with Flex and support a smooth transition.